Davidson Investment Advisors Vertex Pharmaceuticals Inc Transaction History

Davidson Investment Advisors

$2.04 Billion
Q3 2024

A detailed history of Davidson Investment Advisors transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Davidson Investment Advisors holds 48,530 shares of VRTX stock, worth $19.8 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

48,530

Previous 46,339 4.73%

Holding current value

$19.8 Million

Previous $21.7 Million 3.91%

% of portfolio

1.11%

Previous 1.14%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $1.01 Million - $1.11 Million	2,191 Added 4.73%	48,530 $22.6 Million
Q2 2024 Jul 31, 2024	BUY	$392.81 - $485.53 $253,755 - $313,652	646 Added 1.41%	46,339 $21.7 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $478,628 - $523,697	1,174 Added 2.64%	45,693 $19.1 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $6.31 Million - $7.55 Million	-18,392 Reduced 29.23%	44,519 $18.1 Million
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $445,721 - $477,722	1,318 Added 2.14%	62,911 $21.9 Million
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $86,465 - $96,775	275 Added 0.45%	61,593 $21.7 Million
Q1 2023 Aug 22, 2023	SELL	$283.23 - $323.1 $77,888 - $88,852	-275 Reduced 0.45%	61,318 $19.3 Million
Q1 2023 May 02, 2023	BUY	$283.23 - $323.1 $1.82 Million - $2.07 Million	6,415 Added 11.68%	61,318 $19.3 Million
Q4 2022 Feb 02, 2023	BUY	$285.76 - $321.48 $119,447 - $134,378	418 Added 0.77%	54,903 $15.9 Million
Q3 2022 Nov 07, 2022	SELL	$273.83 - $305.53 $3.1 Million - $3.46 Million	-11,337 Reduced 17.22%	54,485 $15.8 Million
Q2 2022 Jul 27, 2022	BUY	$234.96 - $292.55 $139,801 - $174,067	595 Added 0.91%	65,822 $18.5 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $203,263 - $239,570	918 Added 1.43%	65,227 $17 Million
Q4 2021 Jan 28, 2022	SELL	$177.01 - $223.45 $73,105 - $92,284	-413 Reduced 0.64%	64,309 $14.1 Million
Q3 2021 Nov 03, 2021	BUY	$181.39 - $202.99 $462,181 - $517,218	2,548 Added 4.1%	64,722 $11.7 Million
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $11.7 Million - $13.7 Million	62,174 New	62,174 $12.5 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Investment Advisors with notifications on news.

Account

Davidson Investment Advisors Vertex Pharmaceuticals Inc Transaction History